Satellos Bioscience Inc. has established a Scientific Advisory Board composed of leading experts in stem cell biology, regenerative medicine, neuroscience, and small molecule chemistry. The board will guide Satellos' research into the biology of regeneration, aging, and neurodegenerative diseases, expanding beyond its current focus on muscle degenerative diseases. This move aims to deepen scientific understanding and support the development of new therapies, including ongoing clinical trials for forazapadin targeting Duchenne muscular dystrophy and other muscle diseases. The advisory board's expertise is expected to enhance Satellos' long-term scientific strategy and innovation in regenerative medicine.
Satellos Bioscience Inc. is noted here with a Pluang market snapshot for readers following health-related stocks. As of Oct 27, 2026 17:43 WIB, among 150 priced health-sector US stocks tradable on Pluang, 69 rose and 68 fell. Notable movers include XRAY (DENTSPLY SIRONA Inc) at USD 9.42 with a 1-day change of +2.17% and 100% buy order activity, BKD (Brookdale Senior Living Inc.) at USD 9.55 down 2.15%, and AHCO (AdaptHealth Corp) at USD 5.81 down 2.02%.
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a new AI-powered tactical assistant designed to support naval operations by providing enhanced visualizations, automated analyses, and mission-specific recommendations. This system helps naval off...
